IFP Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32
Closed -$1.43K 3513
2023
Q2
$1.43K Sell
32
-6,342
-99% -$279K ﹤0.01% 2980
2023
Q1
$284K Buy
+6,374
New +$279K 0.01% 801
2020
Q1
Sell
-200
Closed -$6K 2967
2019
Q4
$6K Hold
200
﹤0.01% 2128
2019
Q3
$5K Buy
+200
New +$5.08K ﹤0.01% 2353
2019
Q1
Sell
-500
Closed -$11K 3226
2018
Q4
$11K Hold
500
﹤0.01% 2464
2018
Q3
$15K Buy
+500
New +$13.1K ﹤0.01% 2624
2017
Q1
Sell
-1,600
Closed -$24K 4110
2016
Q4
$24K Hold
1,600
﹤0.01% 2335
2016
Q3
$26K Hold
1,600
﹤0.01% 2248
2016
Q2
$26K Buy
+1,600
New +$24.7K ﹤0.01% 2179
2016
Q1
Sell
-1,600
Closed -$26K 3231
2015
Q4
$26K Buy
+1,600
New +$25.6K ﹤0.01% 2018

Other funds holding RXL

IFP Advisors's RXL Position: Q3 2023 in Review

IFP Advisors sold out of ProShares Ultra Health Care (RXL) in Q3 2023, closing a stake of 32 shares — an estimated $1.43K sold.

IFP Advisors first reported a position in RXL in Q4 2015 and held it in 10 quarters. The position peaked at $284K in Q1 2023. 19 funds tracked by Wall St. Rank hold RXL as of Q3 2023.

  • IFP Advisors reported no remaining ProShares Ultra Health Care position as of Q3 2023 after selling out during the quarter.
  • IFP Advisors sold 32 ProShares Ultra Health Care shares in Q3 2023, an estimated $1.43K.
  • IFP Advisors first reported a position in ProShares Ultra Health Care in Q4 2015 and held it in 10 quarters.
  • IFP Advisors's ProShares Ultra Health Care position peaked at $284K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2023.

Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.